Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone vs Cefixime with Doxycycline for Gonorrhea and Chlamydia Coinfection
NCT05216744Phase 2Completed
- Sponsor
- Hai Phong University of Medicine and Pharmacy
- Start
- Jul 2021
- Primary completion
- Feb 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of ceftriaxone, cefixime in gonorrhea, Chlamydia trachomatis infection, sponsored by Hai Phong University of Medicine and Pharmacy. Started Jul 2021; status: completed.
02
Drugs
ceftriaxonecefixime
03
Conditions
gonorrheaChlamydia trachomatis infection
Beyond the preview
Go deeper on NCT05216744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05216744.